AU Patent

AU2021365542B2 — Ready to use, noradrenaline drip bags, having low subvisible particle counts

Assigned to Sintetica SA · Expires 2025-12-11 · 0y expired

What this patent protects

Provided are ready to use drip bags of dilute noradrenaline having improved stability in terms of subvisible particle formation.

USPTO Abstract

Provided are ready to use drip bags of dilute noradrenaline having improved stability in terms of subvisible particle formation.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021365542B2
Jurisdiction
AU
Classification
—
Expires
2025-12-11
Drug substance claim
No
Drug product claim
No
Assignee
Sintetica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.